share_log

Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.

Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.

安進的股票在其與MariTide針對肥胖的二期研究結果公佈後,交易價格下跌。
Benzinga ·  2024/11/26 07:50

Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.

安進的股票在其與MariTide針對肥胖的二期研究結果公佈後,交易價格下跌。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論